- Home
- AUNA vs IMTX Comparison
AUNA vs IMTX Comparison
Compare AUNA & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUNA
- IMTX
- Stock Information
- Founded
- AUNA 1989
- IMTX N/A
- Country
- AUNA Luxembourg
- IMTX Germany
- Employees
- AUNA N/A
- IMTX N/A
- Industry
- AUNA
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AUNA
- IMTX Health Care
- Exchange
- AUNA NYSE
- IMTX Nasdaq
- Market Cap
- AUNA 484.0M
- IMTX 579.8M
- IPO Year
- AUNA 2024
- IMTX N/A
- Fundamental
- Price
- AUNA $6.31
- IMTX $5.52
- Analyst Decision
- AUNA Buy
- IMTX Strong Buy
- Analyst Count
- AUNA 1
- IMTX 4
- Target Price
- AUNA $13.50
- IMTX $14.67
- AVG Volume (30 Days)
- AUNA 62.3K
- IMTX 867.1K
- Earning Date
- AUNA 08-20-2025
- IMTX 08-12-2025
- Dividend Yield
- AUNA N/A
- IMTX N/A
- EPS Growth
- AUNA N/A
- IMTX N/A
- EPS
- AUNA 0.58
- IMTX N/A
- Revenue
- AUNA $1,187,208,994.00
- IMTX $155,801,989.00
- Revenue This Year
- AUNA $6.45
- IMTX N/A
- Revenue Next Year
- AUNA $7.62
- IMTX $1.92
- P/E Ratio
- AUNA $10.87
- IMTX N/A
- Revenue Growth
- AUNA 7.24
- IMTX 93.56
- 52 Week Low
- AUNA $6.13
- IMTX $3.30
- 52 Week High
- AUNA $9.38
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- AUNA N/A
- IMTX 44.11
- Support Level
- AUNA N/A
- IMTX $5.23
- Resistance Level
- AUNA N/A
- IMTX $5.71
- Average True Range (ATR)
- AUNA 0.00
- IMTX 0.29
- MACD
- AUNA 0.00
- IMTX -0.10
- Stochastic Oscillator
- AUNA 0.00
- IMTX 7.83
About AUNA AUNA S A
Auna SA is a healthcare provider. It operates hospitals and clinics in Mexico, Peru, and Colombia, and provides prepaid healthcare plans in Peru, and dental and vision plans in Mexico. Its network includes several healthcare network facilities, consisting of hospitals, outpatient, prevention, and wellness facilities. The company operates in the following segments; Oncosalud Peru and Healthcare services in Peru, Columbia and Mexico. Key revenue is generated from Peru.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.